跳至主要内容
临床试验/NCT03665961
NCT03665961已完成不适用

The Association Between Microbiota, Endotoxaemia and the Host Obesity/ Insulin Resistance (MiPOOP Study)

Changi General Hospital1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2016年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
1
主要终点
Association of human gut microbiome profile with central obesity and dietary pattern

研究概览

简要总结

The objectives of this study are to examine the effects of ethnicity, central obesity and dietary components, on the human gut microbiome. The investigators hypothesize that these factors have an influence on the composition of the gut microbiome. Healthy subjects (n=35) provided stool samples for gut microbiome profiling using 16S rRNA sequencing and completed a dietary questionnaire. The serum samples were assayed for a panel of inflammatory cytokines. Their associations with central obesity were examined.

详细描述

Introduction

Perturbance in the composition of human gut microbiota has been associated with metabolic disorders such as obesity, diabetes mellitus and insulin resistance. The objectives of this study are to examine the effects of ethnicity, central obesity and dietary components, on the human gut microbiome. The investigators hypothesize that these factors have an influence on the composition of the gut microbiome.

Methods: Subjects of Chinese (n=14), Malay (n=10) or Indian (n=11) ancestry, median age 39 (range:22-70 years old), were enrolled. The subjects provided stool samples for gut microbiome profiling using 16S rRNA sequencing and completed a dietary questionnaire. The serum samples were assayed for a panel of biomarkers (Interleukin-6, tumour necrosis factor alpha, adiponectin, cleaved cytokeratin 18, lipopolysaccharide binding protein and limulus amebocyte lysate). Central obesity was defined by waist circumference cut-offs in Asians.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of signed written informed consent,
  • Aged between 21- 75 years old,
  • Body Mass Index (BMI) of > 18 kg/m2,
  • Ethnic group of either Chinese, Malay or Indian as evidenced by identification card,
  • Subject with absence of impaired glucose tolerance,
  • Subject is healthy with no clinically significant disease or condition as determined through their medical history, physical examination; Diabetes mellitus was defined as Type 2 DM fulfilling the WHO criteria and the care of Department of Endocrinology, Changi General Hospital,
  • Ability to communicate with investigator and to understand and comply with all requirements of study participation.

排除标准

  • Subject who are viral Hepatitis (B or C) or HIV positive as per declaration,
  • Subject who had bariatric surgery including lap banding, gastric sleeve surgery, cholecystectomy,
  • Subject who has > 5% weight loss in the last 3 months prior to study enrolment as per declaration,
  • Subject who are on 'stable' insulin sensitizers such as such as rosiglitazone, metformin for the last 3 months prior to enrolment,
  • Pregnant women,
  • Subject who has been treated with antibiotics within 6 weeks of enrolment,
  • Subject who has usage of lactulose, dietary fibres for purpose of constipation,
  • Subject with immune-compromised status; undergoing chemotherapy, on steroid,
  • Subject with FMHx or PMHx of autoimmune disease, GI cancers, inflammatory bowel disease, Irritable bowel syndrome and anxiety or depression as per declaration.

结局指标

主要结局

Association of human gut microbiome profile with central obesity and dietary pattern

时间窗: 1 day

Species diversity as measured by diversity indices

次要结局

  • Association of human gut microbiome profile with ethnicity(1 day)
  • Association of cleaved cytokeratin 18 with central obesity and microbiota(1 day)
  • Association of lipopolysaccharide binding protein with central obesity and microbiota(1 day)
  • Association of tumour necrosis factor - alpha with central obesity and microbiota(1 day)
  • Association of interleukin-6 with central obesity and microbiota(1 day)
  • Association of limulus amebocyte lysate with central obesity and microbiota(1 day)
  • Analysis of dietary components based on recommended daily allowance(3 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John Chen Hsiang

Consultant

Changi General Hospital

研究点 (1)

Loading locations...

相似试验